Authors:
WRENGER E
BAUMANN C
BEHREND M
ZAMORE E
SCHINDLER R
BRUNKHORST R
Citation: E. Wrenger et al., PERITONEAL MONONUCLEAR CELL-DIFFERENTIATION AND CYTOKINE PRODUCTION IN INTERMITTENT AND CONTINUOUS AUTOMATED PERITONEAL-DIALYSIS, American journal of kidney diseases, 31(2), 1998, pp. 234-241
Authors:
WRENGER E
PIRSCH JD
CANGRO CB
DALESSANDRO AM
KNECHTLE SJ
KALAYOGLU M
SOLLINGER HW
Citation: E. Wrenger et al., SINGLE-CENTER EXPERIENCE WITH RENAL-TRANSPLANTATION IN PATIENTS WITH WEGENERS GRANULOMATOSIS, Transplant international, 10(2), 1997, pp. 152-156
Authors:
HAUBITZ M
BRUNKHORST R
WRENGER E
FROESE P
SCHULZE M
KOCH KM
Citation: M. Haubitz et al., CHRONIC INDUCTION OF C-REACTIVE PROTEIN BY HEMODIALYSIS, BUT NOT BY PERITONEAL-DIALYSIS THERAPY, Peritoneal dialysis international, 16(2), 1996, pp. 158-162
Authors:
MEYER M
RICHTER R
BRUNKHORST R
WRENGER E
SCHULZKNAPPE P
KIST A
MENTZ P
BRABANT EG
KOCH KM
RECHKEMMER G
FORSSMANN WG
Citation: M. Meyer et al., URODILATIN IS INVOLVED IN SODIUM HOMEOSTASIS AND EXERTS SODIUM-STATE-DEPENDENT NATRIURETIC AND DIURETIC EFFECTS, American journal of physiology. Renal, fluid and electrolyte physiology, 40(3), 1996, pp. 489-497
Authors:
BRUNKHORST R
WRENGER E
SUHRHOFF J
MEIER M
MANNS MP
KOCH KM
FORSSMANN WG
Citation: R. Brunkhorst et al., EFFECTS OF URODILATIN (URO) ON IMPAIRED SODIUM AND WATER-EXCRETION OFCIRRHOSIS (CL) - RESULTS OF A DOUBLE-BLIND-STUDY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 733-733
Citation: R. Brunkhorst et al., LOW-DOSE PREDNISOLONE CHLORAMBUCIL THERAPY IN PATIENTS WITH SEVERE MEMBRANOUS GLOMERULONEPHRITIS, The Clinical investigator, 72(4), 1994, pp. 277-282
Citation: R. Brunkhorst et al., REVIEW OF THE CYCLOSPORINE TREATMENT IN G LOMERULONEPHRITIS - REVIEW OF THE LITERATURE AND OWN EXPERIENCES, Nieren- und Hochdruckkrankheiten, 22, 1993, pp. 190000012-190000017
Authors:
BRUNKHORST R
WRENGER E
MALCHARZIK C
BRABANT G
KOCH KM
Citation: R. Brunkhorst et al., RENAL EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE IN CIRRHOTIC RATS WITH AND WITHOUT CAPTOPRIL PRETREATMENT, Nephron, 64(2), 1993, pp. 275-281